Task: Answer the multiple-choice question.
Question: Which compound exhibits a 9.261\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Cc1onc(-c2ccccc2)c1C(=O)NC(=S)NNC(=O)c1cc(-c2ccc(F)cc2)n[nH]1
(b) CCC(c1nnnn1Cc1ccccc1)N1CCN(c2ccccc2)CC1
Answer: b. CCC(c1nnnn1Cc1ccccc1)N1CCN(c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(c1nnnn1Cc1ccccc1)N1CCN(c2ccccc2)CC1
CCC(c1nnnn1Cc1ccccc1)N1CCN(c2ccccc2)CC1
1-[1-(1-benzyltetrazol-5-yl)propyl]-4-phenylpiperazine